Humatin, Hartkapseln

7680252290102 CH-25229 Kapseln
Humatin, Hartkapseln
Humatin, Hartkapseln
Humatin, Hartkapseln
1 / 3
google

Article details

Package size
16
Selling units
16
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/08/2021
Patient information leaflet
Français
09/08/2021
Patient information leaflet
Italien
09/08/2021
Summary of Product Characteristics
Allemand
09/08/2021
Summary of Product Characteristics
Français
09/08/2021
Summary of Product Characteristics
Italien
09/08/2021

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
25229
Drug name
Humatin, Hartkapseln
Galenic form
KAHA
ATC Code
A07AA06
Authorization status
Z
Dispensing category
B
First authorization
24/02/1961
Authorization expiration date
31/12/9999
IT Number
08.01.7.
Domain
Human medicine
Field of application
Infektionen des Darmes

Package details

Description (FR)
HUMATIN caps 250 mg bte 16 pce
Description (DE)
HUMATIN Kaps 250 mg Ds 16 Stk
Market launch
24/02/1961
Narcotic (BTM)
No